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ORIGINAL ARTICLE
Prevalence of phocine distemper virus specific
antibodies: bracing for the next seal epizootic in
north-western Europe
Rogier Bodewes1, Danny Morick2, Marco WG van de Bildt1, Nynke Osinga2, Ana Rubio Garcı´a2,
Guillermo J Sa´nchez Contreras2, Saskia L Smits1,3, Leslie AP Reperant1, Thijs Kuiken1
and Albert DME Osterhaus1,3
In 1988 and 2002, two major phocine distemper virus (PDV) outbreaks occurred in harbour seals (Phoca vitulina) in north-western
European coastal waters, causing the death of tens of thousands seals. Here we investigated whether PDV is still circulating among
seals of the Dutch coastal waters and whether seals have protective serum-antibodies against PDV. Therefore seal serum samples,
collected from 2002 to 2012, were tested for the presence of PDV-neutralizing antibodies. Antibodies were detected in most seals in
2002 and 2003 while after 2003 antibodies were detected only in seals less than two month-old and adult seals that probably had
survived the 2002 PDV-epizootic. We estimated the current proportion of seals with antibodies against PDV at 11%. These findings
suggest that at present the vast majority of seals are not immune to PDV infection. PDV re-introduction in this area may cause a major
epizootic with infection of .80% and mass-mortality of .50% of the population.
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INTRODUCTION
Following the introduction of phocine distemper virus (PDV) into
seals in north-western Europe in 1988, the virus spread rapidly causing
severe morbidity and highmortality rates amongmainly harbour seals
(Phoca vitulina) with clinical signs similar to those caused by a related
morbillivirus, canine distemper virus (CDV).1,2 About 22 000 harbour
seals were killed due to infection with the virus and cumulative mor-
tality of the Northern European population was over 50%.3,4 A second
epizootic caused by this virus occurred in 2002 causing the death of
more than 30 000 seals in north-western Europe.3–5 Besides the two
outbreaks of PDV among harbour seals, CDV has caused disease out-
breaks among Baikal seals (Phoca sibirica) in the Siberian Lake Baikal
and among Caspian seals (Phoca caspica) in the Caspian Sea.6–9
Following the second recorded outbreak of PDV infection in 2002,
the population has increased to levels that are at present higher than
before the outbreak.10 Based on the occurrence of two PDV epizootics
among seals of north-western Europe within a relatively short-time
interval and the increase of the population after 2002, another out-
break of PDV epizootic may be expected at some time in the future.11
Since this outbreak will probably again cause high morbidity and
mortality rates, it would be important for both conservation and
management strategies to estimate when such an epizootic could
occur.
Prediction of a novel PDV epizootic is essentially based on estima-
tion of the chance of the re-introduction of PDV into harbour seals of
north-western Europe and on the overall susceptibility of the seal
population. Since PDV is enzootic in Arctic seals and it has been
suggested that grey seals can be immune carriers of the virus,12,13
re-introduction of PDV by migrating seals will probably occur
sooner or later. Alternatively, PDV might have continued to cir-
culate among seals of north-western Europe since the last PDV
epizootic of 2002, as has been suggested after the epizootic in
1988 for seals of the Dutch coastal waters and for other populations
of seals.14,15
However, re-introduction of PDV or introduction of CDV among
the population of harbour seals of north-western Europewill not cause
a new epizootic in the presence of herd immunity. Since it is unknown
how long PDV has been circulating in the population of seals of the
Dutch coastal waters after the last outbreak and to what extent the
population is susceptible to PDV or CDV infection, we evaluated the
presence of antibodies against PDV and CDV in the seal population of
the Dutch coastal waters after the last PDV outbreak in 2002. To this
end, serum samples were collected from seals that were admitted to the
seal research and rehabilitation centre (SRRC) in Pieterburen, the
Netherlands for rehabilitation from 2002 to 2012 and were tested
for the presence of antibodies against PDV and CDV. A simple
mathematical model was built to evaluate the proportion of seals with
immunity in the Wadden Sea population, based on annual seal count
data. It was used to estimate the size of a novel epizootic should the
virus be reintroduced in the population.
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MATERIALS AND METHODS
Sample collection
466 serum samples were collected from seals living in theDutch coastal
waters upon admission to the SRRC in Pieterburen from 2002 to 2012.
Blood samples had been collected for diagnostic purposes and remain-
ing serum was used for research. Of each year, samples were selected
frommainly harbour seals and a number of grey seals of different ages
when available, but also from a ringed seal (Phoca hispida) and a
hooded seal (Cystophora cristata) (Table 1). Seals were divided into
three age categories, pups (at the day of blood collection estimated to
be less than two months of age), juveniles (at the day of blood collec-
tion estimated to be between two and twelve months of age) and
(sub)adults (at the day of blood collection estimated to be older than
one year of age). During and after the outbreak of PDV in 2002 and
2003, seals that were admitted to the SRRC were vaccinated against
PDV using an inactivated CDV vaccine adjuvanted with immune
stimulating complexes as described previously.16,17
Preparation of virus stocks
Virus stocks of CDV strain ‘Bussell’ and PDV (collected from seal
number 89-3418) were prepared by inoculation of confluent flasks
with Vero cells with either strain. When changes were complete, flasks
were frozen and thawed once. The supernatant was subsequently
cleared by low-speed centrifugation, aliquoted and stored at 270 6C.
Titration of virus stocks was performed as described previously.19
Virus neutralization assay
Since both PDVandCDVcould cause newoutbreaks of disease among
seals, serum samples were tested for the presence of antibodies against
PDV and CDV virus as described previously.19 In brief, serum samples
were heat-inactivated for 30 min at 56 6C and subsequently two-fold
serial dilutions of sera were prepared in DMEM (Lonza, Breda,
the Netherlands) containing NaHCO3 (0.15%), Hepes (20 mM),
penicillin (100 U/mL), streptomycin (100 mg/mL) and L-glutamine
(2 mM) in 96 wells flat-bottom plates. Subsequently 100 50% tissue
culture infective dose of each virus added and after incubation for 1 h,
at 37 6C, in 5% CO2, 10
4 Vero-cells were added to each well. Following
4 to 6 days incubation at 37 6C, in 5% CO2, all wells were checked for
the presence of cytopathic changes. Virus neutralizing antibody titers
were calculated as the reciprocal of the highest serum dilution still
giving 100% reduction of cytopathic changes. Antibody titers .10
were considered positive. All antibody titers were determined in
duplicate and serum samples for which cytopathic changes were not
observed due to cytotoxic effects of the serum were excluded from the
study. Serum from a seal collected during the 1988 PDV outbreak was
used as a positive control.
Mathematical modeling
A simplemathematical model was developed, based on earlier work by
Grenfell et al.,20 to evaluate the proportion of individuals immune to
PDV in the harbour seal population, and predict the size of an out-
break should the virus be reintroduced. The model was restricted to
the Wadden Sea harbour seal population because of the availability of
detailed count data for this population.10 Since the harbour seals of the
parts of the Wadden Sea of the Netherlands, Germany and Denmark
are all part of theWadden Sea population, we assumed that the results
of serology of seals fromNetherlands are representative for those from
Germany and Denmark. First, a simple model of the harbour seal
population dynamics was developed, assuming logistic growth of
the population in an environment with a carrying capacity K of
38 000.21
dN
dt
~rN 1{
N
K
 
Equation 1
With r, the intrinsic growth rate of the population:
r~a{b
Where a and b are the individual birth rate and death rate, respec-
tively. As previously, we ignored the seasonality of birth and age struc-
ture of the population.20 Yearly estimates of the Wadden Sea harbour
seal population from 1975 to 2011 were obtained from.10 The model
(Equation 1) was fitted to the data using the least square method. The
model was fitted separately for the period 1975–1988, 1989–2002 and
2003–2011. Parameter values are indicated in Supplementary Table S1.
We further used the simple disease dynamics model of the
Susceptible-Infected-Recovered (SIR)-type proposed by Grenfell
et al.20 to model the epizootics of 1988 and 2002.
dS
dt
~{bSI
Equation 2
dI
dt
~bSI{aI
Table 1 Overview of serum samples of seals used in this study
Year All seals Harbour seals Grey seals Other
Total Pup Juvenile (Sub)adult Total Pup Juvenile (Sub)Adults
2002 48 44 9 35 0 3 3 0 0 1*
2003 50 50 38 12 0 0 0 0 0 0
2004 41 32 16 13 3 9 2 7 0 0
2005 44 35 19 16 0 8 5 3 0 1**
2006 42 36 22 12 2 6 3 2 1 0
2007 49 44 7 36 1 5 5 0 0 0
2008 49 47 4 41 2 2 2 0 0 0
2009 51 51 27 23 1 0 0 0 0 0
2010 13 13 3 9 1 0 0 0 0 0
2011 52 50 16 33 1 2 0 1 1 0
2012 23 21 0 21 0 2 2 0 0 0
* ringed seal
** hooded seal
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dR
dt
~(1{d)aI
Susceptible individuals (S) become infected (I) at a rate b. Once
infected, they remain infectious for a duration of 1/a. A proportion of
(12d) recovers, while a proportion of d dies from infection. Recovered
individuals (R) remain immune to re-infection with PDV for the rest
of their lives. Since the dynamics of the 2002 epizootic were shown
closely similar to those of 1988,22 parameters estimated by Grenfell
et al.20 based on the 1988 epizootic were used for both the 1988 and the
2002 epizootics (Supplementary Table S1), Because of the short dura-
tion of the epizootics (several weeks), we ignored birth and death
processes in the disease dynamics model.20 Here also, we ignored
the age structure of the population because of the paucity of data on
the forces of PDV transmission among and between different age
classes. The model allowed determining the proportion of susceptible
and immune (recovered) individuals at the end of the epizootics.
These proportions were used in the population model (Equation 1)
to follow through time the number of susceptible and immune hosts in
the population (with N, the total number of individuals):
N~SzR
Equation 3
dR
dt
~{bR
In this model, we estimated the number of pups with maternal
antibodies separately, using Equation 1. All pups born from immune
individuals were considered passively immune to PDV due to mater-
nal antibodies. These individuals entered the susceptible class (S) three
months after birth.23,24
The disease dynamics model was then used to estimate the size of
future epizootics should PDV be reintroduced in the Wadden Sea
harbour seal population.
RESULTS
Antibodies against PDV and CDV in harbour seals
PDV neutralizing antibodies were detected in 70 out of 423 tested
serum samples (17%) collected from harbour seals. From all positive
samples, 52 had been collected from seals admitted to the SRRC in
2002 and 2003 (74%of all positive samples) during or the year after the
PDV epidemic (Figure 1A). After 2003, antibodies were only detected
in samples from eleven seal pups and seven (sub)adult seals and not in
samples from juvenile seals (Figures 1B, 1C and 1D). Geometric mean
(antibody) titer (GMT) of all positive sera was 52 (SD 33). TheGMTof
positive samples of harbour seals of all ages in 2002 and 2003 was 60
(SD 38). After 2003, lower antibody titers were detected in seal pups
(GMT 35, SD 28), but not in adult seals (GMT 96, SD 32). Data of all
age groups for all years are indicated in Supplementary Table S2.
Antibodies against CDV were detected in 58 out of 423 serum
samples (14%), mainly in 2002 and 2003 (84% of the positive sam-
ples). The GMT against CDV of all positive sera was 60 (SD 31). In 15
samples antibodies were detected against PDV, but not against CDV,
while in three samples antibodies against CDV were detected but not
against PDV. In all other samples, antibodies were detected against
both viruses or nomorbillivirus-specific antibodies were detected. The
presence of antibodies against CDV correlated with the presence of
antibodies against PDV and vice versa (Phi correlation coefficient
rW50.8), but no correlation was observed between the antibody titer
against both viruses in the positive serum samples (Pearson correla-
tion coefficient r520.002).
Antibodies against PDV and CDV in other seal species
The presence of antibodies against PDV and CDV was also studied in
serum samples collected from 37 grey seals. PDV specific antibodies
were detected in four samples (11% of all tested sera); in two serum
samples from pups in 2002 (titer of 80 and 20), in serum of a pup in
2005 (titer of 20) and an adult seal in 2006 (titer of 80). Antibodies
against CDVwere only detected in one of the pups in 2002 (titer of 20)
and in the adult seal (titer of 20). No PDV or CDV-specific antibodies
weredetected in the two serumsamplesof the ringed seal andhooded seal.
Mathematical modelling
The model of population dynamics of harbour seals in the Wadden
Sea was fitted to data10 for the periods of 1975–1988, 1989–2002 and
2003–2011, and captured well the observed growth of the population
(Figure 2). Likewise, the model of disease dynamics using estimated
parameters fromGrenfell et al.20 captured well the significant drops in
the harbour seal population in 1988 and 2002 (Figure 2). At the end of
the 1988 epizootic, the model predicted that less than 5% of the popu-
lation had not been infected by PDV, while 60% had died of the
disease, and 35% recovered. At the end of the 2002 epizootic, close
to 6% of the population had not been infected with PDV, while 57%
Figure 1 Proportion of harbour seals of different ages with antibodies against
PDV. Proportion of serum samples of each year positive for PDV antibodies of all
harbour seals (A), or only pups (B), juvenile seals (C) or (sub)adults (D). N.D. (no
data) indicates that no samples of that year were tested.
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died of the disease and 37% recovered. These estimates are in accor-
dance with the mortality rates observed during the 1988 and 2002
epizootics.3,4
The model predicted that the harbour seal population in the
Wadden Sea was constituted of 87% of immune individuals and
13% of susceptible individuals after the 2002 epizootic. These propor-
tions decreased to reach 11% and 89%, respectively, in 2012. Because
maternal antibodies are of parental origin, the proportion of pups of
the year with antibodies against PDV is a valuable indicator of the
proportion of immune individuals in the entire population that were
exposed to PDV in previous years. The presence of maternal antibo-
dies reflects the presence of immunity in reproductive females,
because pups infected with PDV, orphaned or abandoned during an
epidemic will not survive and pregnant females will most likely abort
following PDV infection.3,20 As the age structure of the individuals
sampled for this study unlikely reflects that of the population, the
proportion of pups with maternal antibodies can thus be used to
evaluate the model results. The predicted proportion of immune pups
from 2002 to 2012 matches well the serological data (Figure 3). The
model therefore captures well the proportions of susceptible and
immune seals in the population through time, and can be used to
predict how these proportions will change in the future.
Supplementary Figure S1 shows changes in the number of susceptible
and immune hosts in the entire Wadden Sea population over time,
from 2003 to 2030. Figure S1 also shows changes into the correspond-
ing size of a new epizootic should PDV be reintroduced into the
population. Based on a proportion of immune individuals of 11%
in the population in 2012, a new PDV epizootic would result in the
death of 52% of the population at this time. As the population con-
tinues to grow to carrying capacity levels, the mortality burdens of an
epizootic would reach the levels of previous epizootics (.55%) by
2017.
DISCUSSION
In the present manuscript, we evaluated the presence and distribution
of virus neutralizing-serum-antibodies against PDV and CDV in seals
of the Dutch coastal waters that had been admitted to the SRRC for
rehabilitation from 2002 to 2012. Antibodies were detected in the
majority of seals admitted to the SRRC in 2002 and 2003. Both the
PDV outbreak in spring 2002 and the possible use of vaccines to
prevent spread of PDV among seals in the SRRC in 2002 and 2003
account for the high proportion of seals with antibodies against
either CDV or PDV in those years. As demonstrated previously, the
presence of antibodies against PDV correlated with the presence of
antibodies against CDV but the levels of antibodies against PDV and
CDV did not correlate as has been observed previously.19 After 2003,
antibodies were only detected in seals younger than twomonths of age
and in adult seals. No antibodies were detected in serum samples of
Figure 2 Population growth of harbour seals of the whole Wadden Sea from 1975 to 2011 and estimated number of seals susceptible to and immune against PDV.
Annual count data collected during aerial surveys and corrected for unobserved animals10 are shown as grey circles. The estimated numbers of susceptible seals,
immune seals, and of the total population are represented with the dashed line, dotted line and plain line, respectively.
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Figure 3 Comparison of measured and estimated proportion of harbour seal
pups with maternal antibodies against PDV. The proportion of serum samples
of pups positive for PDV antibodies is represented with grey bars with the upper
95%confidence interval. The upper 95%confidence intervals for the years 2007,
2008 and 2010 are not shown because of the small number of sampled indivi-
duals. No samples were collected in pups in 2012. The estimated proportion of
pup seals with maternal antibodies is represented with the plain line.
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juvenile seals, despite the high number of seals of this age tested
(n5242).
Although we tested only a small proportion of the seal population and
the seals admitted to the SRRC may not be representative of the popu-
lation of seals of north-western Europe, results of the present study
suggest that seals of this area, born after 2003 do not have antibodies
against PDV and CDV after twomonths of age. In addition, results from
our study indicate that during the past ten years PDV has not been
introduced into the harbour seal population of north-western Europe.
Transfer of maternal antibodies to pups are probably the reason for
the presence of antibodies in seal pups since it has been demonstrated
that CDV antibodies can be transferred frommother to pup in dogs.23
Maternal antibodies are only present until three months of age, which
explains the absence of detectable antibodies in seals between two and
twelve months of age. Based on the estimation of the age of adult seals
with antibodies, all these animals were born before the outbreak of
PDV in 2002. The presence of antibodies in these seals is probably due
to infection during the outbreak in 2002 and 2003.
Based on a simple mathematical model, we estimated the percentage
of harbour seals in theWadden Sea that currently has protective immun-
ity against PDV due to previous infection or vaccination to be of the
order of 11%. This proportion of immune individuals is not sufficient to
provide effective herd immunity against PDV should it be re-introduced
in the population. A novel epizootic at this time would affect 82% of the
population resulting in the death of more than 18 000 seals in the
Wadden Sea. These are high figures, considering that it is only 10 years
since the last epizootic. The high growth rate of the seal population since
2002 explains at least in part the predictions of the models, due to high
recruitment of susceptible individuals through birth. As the population
continues to grow, the burdens of a new epizootic will increase to reach
the levels of historical epizootics within the next few years.
The absence of sufficient herd immunity among the population of
harbour seals of the Dutch coastal waters indicates that the occurrence
of a novel PDV or CDV epizootic depends only on introduction of the
virus into this population, e.g. by migrating seals. The increasing
number of seals in the Dutch coastal waters might affect the migration
patterns of seals. Since the last outbreak of PDV infection in 2002 in
Northern Europe, outbreaks of this virus infection have been demon-
strated in seals of the east coast of the United Stated and in northern
sea otters in the Pacific Ocean (Alaska, United States).25–27 Further-
more, it has been demonstrated that this virus is enzootic in arctic
seals.12 These studies indicate that PDV is still circulating and although
the exact moment of the next PDV epizootic among harbour seals of
Northern Europe can not be foreseen, another epizootic among har-
bour seals of north-western Europe will occur sooner or later, and will
likely again result in heavy morbidity and mortality burdens.
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